Kayne Anderson MLP/Midstream Investment Company Provides Strategic Update
HOUSTON, July 27, 2020 (GLOBE NEWSWIRE) —KYN is expanding its focus areas within energy infrastructure to include portfolio allocations to […]
HC2 Holdings to Announce Second Quarter 2020 Financial Results
NEW YORK, July 27, 2020 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (NYSE:HCHC), a diversified holding company, announced today that it […]
Park National Corporation reports financial results for second quarter and first half of 2020
NEWARK, Ohio, July 27, 2020 (GLOBE NEWSWIRE) — Park National Corporation (Park) (NYSE American: PRK) today reported financial results for […]
Kayne Anderson Midstream/Energy Fund Provides Strategic Update
HOUSTON, July 27, 2020 (GLOBE NEWSWIRE) —KMF is being repositioned to focus on key trends and developments within the energy […]
EMCORE Corporation to Host Fiscal 2020 Third Quarter Conference Call on August 6, 2020
ALHAMBRA, Calif., July 27, 2020 (GLOBE NEWSWIRE) — EMCORE Corporation (NASDAQ: EMKR), a leading provider of advanced mixed-signal products that […]
Aerojet Rocketdyne Holdings, Inc. Reports 2020 Second Quarter Results
EL SEGUNDO, Calif., July 27, 2020 (GLOBE NEWSWIRE) — Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD) today reported results for the three […]
Lumos Pharma Announces Sale of Priority Review Voucher
AUSTIN, Texas, July 27, 2020 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for […]
Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East
SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum […]
Grocery Outlet Holding Corp. Announces Second Quarter Fiscal 2020 Earnings Release and Conference Call Date
EMERYVILLE, Calif., July 27, 2020 (GLOBE NEWSWIRE) — Grocery Outlet Holding Corp. (NASDAQ: GO) (“Grocery Outlet”) today announced that its […]
Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR006
NEW YORK, July 27, 2020 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene […]
